复星医药频“瘦身”

北京商报
14 Apr

复星医药(600196)正在加速瘦身。公司最新公告显示,拟转让上海复健55%股权,持股比例降至45%。此次交易系根据中基协等相关最新规定而作出调整。与此次资产剥离相比,此前复星医药的资产运作更能体现公司现阶段的发展规划。就在上个月,复星医药刚刚宣布彻底退出和睦家,预计将为公司贡献税后收益约6.5亿元。此外,在2024年业绩说明会上,复星医药董事长吴以芳表示,2025年还将继续加大回笼资金力度。持续...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10